Hai Nguyen, DO
Interventional Pain Medicine · Spring, TXNPI 1790196897
Payments from drug & device makers
Across 400 payments — averaging $50.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Saluda Medical Americas, Inc.$3K
- Genesys Orthopedics Systems, L.L.C.$3K
- Spinal Simplicity, LLC$728
- Nevro Corp.$648
- Nalu Medical, Inc.$436
- plus $2K from 13 others
What the payments were for
- Consulting fees$1,5007%
- Travel & lodging$4,95925%
- Food & beverage$13,53367%
- Gifts$640%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 304 | $10,205 |
| Saluda Medical Americas, Inc. | 19 | $3,363 |
| Genesys Orthopedics Systems, L.L.C. | 8 | $3,123 |
| Spinal Simplicity, LLC | 10 | $728 |
| Nevro Corp. | 10 | $648 |
| Nalu Medical, Inc. | 18 | $436 |
| Abbott | 4 | $241 |
| Globus Medical | 6 | $234 |
| Si-bone, Inc. | 4 | $212 |
| Edwards Lifesciences | 1 | $197 |
| Vertos Medical, Inc. | 3 | $178 |
| SPR Therapeutics, Inc | 2 | $148 |
| Painteq LLC | 2 | $99 |
| Curonix LLC | 4 | $82 |
| Boston Scientific | 1 | $77 |
| Biotronik NRO, Inc. | 1 | $29 |
| Vertex | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SACROILIAC JOINT FUSION SYSTEM$3,527
- Evoke$3,062
- INTELLIS ADAPTIVESTIM$2,538
- KYPHON Balloon Kyphoplasty$1,071
- SYNCHROMEDII$1,053
- HA MINUTEMAN G3-R$573
- Senza$403
- VECTRIS$364
- HemoSphere$197
- KYPHON EXPRESS II KYPHOPAK TRAY$147
- SYNCHROMED$145
- Nalu Neurostimulation System$142
- SPRINT PNS System$141
- ASCENDA$134
- INTELLIS$104
- VECTRIS SURESCAN$102
- mild Device Kit$101
How this compares
$20,056 in reported general payments places this provider in the 75th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,318 | $39,265 |
| Xtampza ErOxycodone Myristate | 24 | $15,937 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $10,882 |
| BelbucaBuprenorphine Hcl | 13 | $10,039 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $7,263 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 204 | $5,110 |
| Naloxone Hcl | 70 | $4,434 |
| Gabapentin | 154 | $2,246 |
| Hydromorphone Hcl | 63 | $1,700 |
| Tizanidine Hcl | 135 | $1,627 |
| Buprenorphine | 13 | $1,586 |
| Pregabalin | 67 | $1,555 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 81 | $1,554 |
| Cyclobenzaprine Hcl | 134 | $1,272 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $1,094 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $16 | $25,97537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Spring
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
- Ankur KhoslaShenandoah$511K
- Brian RichDecatur$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.